The rapamycin-regulated gene expression signature determines prognosis for breast cancer
<p>Abstract</p> <p>Background</p> <p>Mammalian target of rapamycin (mTOR) is a serine/threonine kinase involved in multiple intracellular signaling pathways promoting tumor growth. mTOR is aberrantly activated in a significant portion of breast cancers and is a promisin...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-09-01
|
Series: | Molecular Cancer |
Online Access: | http://www.molecular-cancer.com/content/8/1/75 |